INTERCEPT PHARMACEUTICALS, INC. Annual Depreciation in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Intercept Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from 2010 to 2022.
  • Intercept Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2023 was $89K, a 73.9% decline year-over-year.
  • Intercept Pharmaceuticals, Inc. annual Depreciation for 2022 was $592K, a 79% decline from 2021.
  • Intercept Pharmaceuticals, Inc. annual Depreciation for 2021 was $2.81M, a 4.38% decline from 2020.
  • Intercept Pharmaceuticals, Inc. annual Depreciation for 2020 was $2.94M, a 19.7% decline from 2019.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $592K -$2.22M -79% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-02
2021 $2.81M -$129K -4.38% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-02
2020 $2.94M -$720K -19.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-02
2019 $3.66M -$919K -20.1% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-02
2018 $4.58M -$19K -0.41% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $4.6M +$770K +20.1% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-25
2016 $3.83M +$2.14M +127% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 $1.69M +$1.25M +282% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-28
2014 $443K +$337K +318% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-01
2013 $106K -$95.3K -47.3% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 $201K -$209K -51% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-02
2011 $411K -$68.9K -14.4% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-14
2010 $480K Jan 1, 2010 Dec 31, 2010 10-K 2013-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.